These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24076599)

  • 1. Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.
    Yazdani C; Hanna N
    J Pharm Pract; 2014 Feb; 27(1):53-60. PubMed ID: 24076599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
    Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
    Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
    Tsoulas C; Nathwani D
    Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
    Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
    McCollum M; Sorensen SV; Liu LZ
    Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
    Itani KM; Dryden MS; Bhattacharyya H; Kunkel MJ; Baruch AM; Weigelt JA
    Am J Surg; 2010 Jun; 199(6):804-16. PubMed ID: 20227056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does vancomycin have a future in the treatment of skin infections?
    O'Brien DJ; Gould IM
    Curr Opin Infect Dis; 2014 Apr; 27(2):146-54. PubMed ID: 24526063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalist perspective on the treatment of skin and soft tissue infections.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Mayo Clin Proc; 2014 Oct; 89(10):1436-51. PubMed ID: 24974260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid versus vancomycin for skin and soft tissue infections.
    Yue J; Dong BR; Yang M; Chen X; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008056. PubMed ID: 26758498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN; Shively EH; Polk HC
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis.
    Willke RJ; Glick HA; Li JZ; Rittenhouse BE
    Int J Technol Assess Health Care; 2002; 18(3):540-54. PubMed ID: 12391947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.